3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urinary Bladder Neoplasms
40
Carcinoma, Transitional Cell
3
Muscle Invasive Bladder Cancer
2
Infiltrating Bladder Urothelial Carcinoma
2
Carcinoma, Renal Cell
2
Urologic Neoplasms
1
Urologic Diseases
1
Urinary Bladder Diseases
1
Ureteral Neoplasms
1
Transitional Cell Carcinoma of the Bladder
1
Transitional Cell Bladder Cancer
1
Stage 0is Bladder Urothelial Carcinoma
1
Prostatic Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Non-metastatic Muscle Invasive Bladder Cancer
1
Invasive Bladder Cancer
1
Ileus
1
Cone Dystrophy 3
1
Bladder Adenocarcinoma
1
Adrenal Gland Neoplasms
1
Interventions
tremelimumab
1
durvalumab
1
Sodium Chloride
1
Radiotherapy
1
Lidocaine
1
Hyperthermic Intraperitoneal Chemotherapy
1
Cystectomy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Invasive Bladder Cancer
×
Cystectomy
×
Clear all
NCT02924480
2022-03-09
Lidocaine
CAMC Health System
Phase NA
Completed
50 enrolled